Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.

Literature DB >> 18709327

Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.

Agnieszka Wojtkiewicz, Mariusz Wysocki, Jacek Fortuna, Małgorzata Chrupek, Maciej Matczuk, Andrzej Koltan.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2008 PMID： 18709327 DOI： 10.2340/00015555-0462

Source DB: PubMed Journal: Acta Derm Venereol ISSN： 0001-5555 Impact factor: 4.437

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Authors: Chuang-Wei Wang; Lan-Yan Yang; Chun-Bing Chen; Hsin-Chun Ho; Shuen-Iu Hung; Chih-Hsun Yang; Chee-Jen Chang; Shih-Chi Su; Rosaline Chung-Yee Hui; See-Wen Chin; Li-Fang Huang; Yang Yu-Wei Lin; Wei-Yang Chang; Wen-Lang Fan; Chin-Yi Yang; Ji-Chen Ho; Ya-Ching Chang; Chun-Wei Lu; Wen-Hung Chung
Journal: J Clin Invest Date: 2018-02-05 Impact factor: 14.808

Review 2. Skin manifestations of drug allergy.

Authors: Michael R Ardern-Jones; Peter S Friedmann
Journal: Br J Clin Pharmacol Date: 2011-05 Impact factor: 4.335

Review 3. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.

Authors: S Shahzad Mustafa; David Ostrov; Daniel Yerly
Journal: Curr Allergy Asthma Rep Date: 2018-03-24 Impact factor: 4.806

Review 4. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

Authors: Audrey Jacobsen; Bayanne Olabi; Annie Langley; Jennifer Beecker; Eric Mutter; Amanda Shelley; Brandon Worley; Timothy Ramsay; Arturo Saavedra; Roses Parker; Fiona Stewart; Jordi Pardo Pardo
Journal: Cochrane Database Syst Rev Date: 2022-03-11

Review 9. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.

Authors: Jeremy A Schneider; Philip R Cohen
Journal: Adv Ther Date: 2017-04-24 Impact factor: 3.845

10. Blisters and Loss of Epidermis in Patients With Lupus Erythematosus: A Clinicopathological Study of 22 Patients.

Authors: Carine Merklen-Djafri; Didier Bessis; Camille Frances; Nicolas Poulalhon; Sébastien Debarbieux; Nadège Cordel; Dan Lipsker
Journal: Medicine (Baltimore) Date: 2015-11 Impact factor: 1.817

Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.

1. Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Review 2. Skin manifestations of drug allergy.

Review 3. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.

Review 4. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

5. Cephalosporin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin.

Review 6. Treatments for Severe Cutaneous Adverse Reactions.

Review 7. Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective.

Review 8. Biologics in dermatology: an integrated review.

Review 9. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.

10. Blisters and Loss of Epidermis in Patients With Lupus Erythematosus: A Clinicopathological Study of 22 Patients.